Photo of boy swimming forward: we are working to make a difference for patients with rare endocrine diseases and cancer

We’ve got making a difference for patients down to a science

Explore our technology

Photo: 2 women in supportive embrace: we are working to make a difference for caregivers of patients w/endocrine rare disease & cancer

We’ve got making a difference for caregivers down to a science

LEARN ABOUT OUR VISION

Photo of child & physician: we are working to make a difference for physicians treating patients with rare endocrine diseases & cancer

We’ve got making a difference for physicians down to a science

Discover our pipeline

Photo of woman working in a lab: we are making a difference for employees

We’ve got making a difference for employees down to a science

Find Career Opportunities

With TransCon™ technology, this is just the start

Our powerful technology platform —combined with a unique algorithm for sustainable product innovation — is focused on making a meaningful difference in patients’ lives. And there’s more to come.

WATCH VIDEO

A pipeline with the potential to impact patient lives worldwide

We have three endocrinology rare disease product candidates in clinical development, and a pipeline of oncology candidates closely following.

Discover our pipeline

TransCon hGH, an investigational GHD therapy administered once weekly

Our investigational growth hormone prodrug releases somatropin (rhGH or hGH) with once-weekly administration. Marketing applications have been submitted in the United States and Europe for pediatric growth hormone deficiency (GHD).

Learn More

We are passionate about patients and science

We are a dynamic place to grow and learn with a unique global culture and entrepreneurial spirit.

Join Us